Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Hong Lee

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Stroke Journal|January 30, 2026
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trialJae-Sung Lim, Joung-Ho Rha, Jong-Ho Park, et al.
European Stroke Journal|August 29, 2025
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trialJae-Sung Lim, Joung-Ho Rha, Jong-Ho Park, et al.
Contemporary Clinical Trials|February 1, 2023
Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trialJae-Sung Lim, Juneyoung Lee, Yeonwook Kang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 7, 2023
Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosisTae Jung Kim, Ji Sung Lee, Jae Sun Yoon, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Stroke Journal|January 30, 2026
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trialJae-Sung Lim, Joung-Ho Rha, Jong-Ho Park, et al.
European Stroke Journal|August 29, 2025
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trialJae-Sung Lim, Joung-Ho Rha, Jong-Ho Park, et al.
Contemporary Clinical Trials|February 1, 2023
Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trialJae-Sung Lim, Juneyoung Lee, Yeonwook Kang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 7, 2023
Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosisTae Jung Kim, Ji Sung Lee, Jae Sun Yoon, et al.
Pageof 5